2nd Circ. Skeptical Of Bid To Boost Drug Royalty Award
By Caroline Simson · May 20, 2026, 9:06 PM EDT
A Second Circuit panel appeared unsympathetic during oral arguments on Wednesday to Acorda Therapeutics Inc.'s assertion that it should be awarded nearly $66 million beyond the $16.5 million it won in...
To view the full article, register now.